Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 53,811 | 3,181 |
| Gross Profit | N/A | N/A | 0 | 53,811 | 3,181 |
| Operating Expenses | 59,785 | 48,769 | 41,864 | 39,739 | 44,148 |
| Operating Income | -59,785 | -48,769 | -41,864 | 14,072 | -40,967 |
| Other Income | 4,445 | 3,256 | 3,060 | 1,802 | 2,149 |
| Pre-tax Income | -55,340 | -45,513 | -38,804 | 15,874 | -38,818 |
| Income Tax | 1 | 1 | -55 | -10 | 35 |
| Net Income Continuous | -55,341 | -45,514 | -38,749 | 15,884 | -38,853 |
| Net Income | $-55,341 | $-45,514 | $-38,749 | $15,884 | $-38,853 |
| EPS Basic Total Ops | -0.37 | -0.32 | -0.30 | 0.14 | -0.35 |
| EPS Basic Continuous Ops | -0.37 | -0.32 | -0.30 | 0.14 | -0.35 |
| EPS Diluted Total Ops | -0.37 | -0.32 | -0.29 | 0.13 | -0.35 |
| EPS Diluted Continuous Ops | -0.37 | -0.32 | -0.30 | 0.13 | -0.35 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.32 | -0.29 | 0.13 | -0.35 |
| EBITDA(a) | $-60,305 | $-49,430 | $-42,153 | $14,067 | $-41,064 |